GPC3 and cancer: Notably, potent anti‐cancer cytotoxicity was confirmed against Hep3B cells which were GPC3‐positive, whereas minimal cytotoxicity was observed with PLC/PRF/5 cells which were detected as GPC3‐negative (Figure 1C; Figure S1).